The aim of the randomized controlled trial (RCT) is to evaluate the efficacy of an innovative, personalized intervention for smoking cessation among smokers in socio-economically precarious situations. Recruited between March 2021 and March 2024, this multicenter RCT included participants recruited from 17 health centers in 7 French cities.
Smokers were divided into a control group (standard care) and an intervention group, where they could choose, free of charge, between various nicotine substitutes (patches, gums, inhalers, tablets) and/or an electronic cigarette to support them in their quit attempt.
Project funding : Institut National du Cancer (INCA).
ESSMA Team members involved: Fabienne EL-KHOURY, Maria MELCHIOR, Marie Noel AL ZAYAT
Collaborations : la Société Francophone de tabacologie (SFT), la Société de Formation du Thérapeutique du Généraliste (SFTG).
Our team is located on a single site, on the 3rd floor of the Pierre et Marie Curie Faculty of Medicine, Pôle Saint-Antoine
27 rue de Chaligny
Paris 12°
Tél.: +(33) 01.44.73.84.45
Métro : Faidherbe-Chaligny (8), Reuilly Diderot (1)
Bus : 46 – 86
Vélib : Station 1108, 223 rue du Faubourg Saint-Antoine
